Cargando…

A CD8(+) T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates

γ1-Herpesviruses such as Epstein-Barr virus (EBV) have a unique ability to amplify virus loads in vivo through latent growth-transforming infection. Whether they, like α- and β-herpesviruses, have been driven to actively evade immune detection of replicative (lytic) infection remains a moot point. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hislop, Andrew D., Ressing, Maaike E., van Leeuwen, Daphne, Pudney, Victoria A., Horst, Daniëlle, Koppers-Lalic, Danijela, Croft, Nathan P., Neefjes, Jacques J., Rickinson, Alan B., Wiertz, Emmanuel J.H.J.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2007
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118677/ https://www.ncbi.nlm.nih.gov/pubmed/17620360 http://dx.doi.org/10.1084/jem.20070256

Ejemplares similares

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
por: Croft, Nathan P., et al.
Publicado: (2009)

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
por: Zuo, Jianmin, et al.
Publicado: (2009)

CD8(+) immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
por: Pudney, Victoria A., et al.
Publicado: (2005)

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
por: Gram, Anna M., et al.
Publicado: (2016)

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
por: van Gent, Michiel, et al.
Publicado: (2014)

Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)

Epitope-specific Evolution of Human CD8(+) T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection
por: Hislop, Andrew D., et al.
Publicado: (2002)

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases
por: Abbott, Rachel J., et al.
Publicado: (2017)

Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology
por: Rowe, Martin, et al.
Publicado: (2009)

Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
por: Thomas, Olivia G, et al.
Publicado: (2023)

Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity
por: Jayasooriya, Shamanthi, et al.
Publicado: (2012)

An update: Epstein-Barr virus and immune evasion via microRNA regulation
por: Zuo, Lielian, et al.
Publicado: (2017)

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8(+) T Cell Recognition across All Three Phases of the Lytic Cycle
por: Quinn, Laura L., et al.
Publicado: (2014)

Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta
por: Almohammed, Rajaei, et al.
Publicado: (2018)

Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines
por: Hooykaas, Marjolein J. G., et al.
Publicado: (2016)

Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children
por: Jayasooriya, Shamanthi, et al.
Publicado: (2015)

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
por: Voisset, Cécile, et al.
Publicado: (2014)

Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP
por: Koppers-Lalic, Danijela, et al.
Publicado: (2008)

Characterization of the CD4(+) T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection
por: Amyes, Elisabeth, et al.
Publicado: (2003)

Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8(+) T cell immunity
por: Rowe, Martin, et al.
Publicado: (2010)

Circulating platelets as liquid biopsy sources for cancer detection
por: Antunes‐Ferreira, Mafalda, et al.
Publicado: (2020)

Liquid Biopsy: Current Status and Future Perspectives
por: Baev, Vesselin, et al.
Publicado: (2023)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2023)

Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection
por: Palser, Anne L., et al.
Publicado: (2015)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
por: Brooks, Jill M., et al.
Publicado: (2016)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution
por: Verweij, Marieke C., et al.
Publicado: (2015)

Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response
por: Steven, N.M., et al.
Publicado: (1997)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Direct Visualization of Antigen-specific CD8(+)T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo
por: Callan, M.F.C., et al.
Publicado: (1998)

Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA
por: Lista, María José, et al.
Publicado: (2017)

CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1
por: Lee, Steven P., et al.
Publicado: (2004)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b9u9l0o5apf4e5q0ctsfaaoa24